Lodaat Pharma

Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products.  USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets.  Many products are made in USA products in FDA approved facilities.

Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules.  We are looking for reputable global partners who want to expand their product line and in-license for their territory.

USFDA Oral Solid Dosages in major Therapeutic categories.  All products are USFDA registered and available in either Zone II or Zone IV stability studies.  Full dossiers available in either ECTD or CTD formats

LODAAT's Oral Solid Dosages are EU-GMP facility approved and are available in innovations such as ODT, Sachets, and Extended Release.  Our facilities handle all testing, production and full packaging capabilities.

LODAAT produces the best quality USA made Vitamins, Herbal supplements, Minerals and OTC products.  Our finished formulations are available in Tablets and Capsules.  We have 3 US facilities producing Private Label and Branded goods in Bottles and Blister packaging.  Best selling products inc...

Lodaat's Oncology Colombian INVIMA approved injectables with CTD dossier

CPHI Frankfurt, to be held at Messe Frankfurt from October 28–⁠30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our interview series sits down with some of our conference track sponsors and speakers to discuss key themes and trends impacting the industry.

This video provides an Introduction to the LODAAT team, product categories, facilities, research and innovation.

In this episode Lucy Chard is joined by Rajiv Khatau to discuss the importance of looking into new therapeutic areas and some of the more niche areas of pharmaceuticals, and investing in the future of the industry. 

In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conference.  

At CPHI Barcelona (24–26 October, 2023) we took the time to catch up with one of our speakers, Rajiv Khatau who gave a presentation on: The Microbiome Boom - Unlocking Potential Through Listening to the Gut and was a panellist on: Why Building a Collaborative Network is Essential for Rare Disease Therapies.